Mesenchymal Stromal Cells for the Treatment of Patients With COVID-19.

Stopped No patient could be included because there was a decrease in the number of patients with complications due to COVID-19. Also, a Brazilian government agency approved this clinical trial, and the project execution period ended in March 2023.

Conditions

• COVID-19 Pneumonia
• COVID-19

Interventions

• BIOLOGICAL: Mesenchymal stem cell
• OTHER: Placebo

Sponsor

Paulo Brofman

Collaborators

• [object Object]